WO2012144754A3 - Composition contenant un extrait de galla rhois présentant des effets inhibiteur de virus, ou un composé isolé à partir de celui-ci, comme ingrédient actif et ses utilisations - Google Patents

Composition contenant un extrait de galla rhois présentant des effets inhibiteur de virus, ou un composé isolé à partir de celui-ci, comme ingrédient actif et ses utilisations Download PDF

Info

Publication number
WO2012144754A3
WO2012144754A3 PCT/KR2012/002450 KR2012002450W WO2012144754A3 WO 2012144754 A3 WO2012144754 A3 WO 2012144754A3 KR 2012002450 W KR2012002450 W KR 2012002450W WO 2012144754 A3 WO2012144754 A3 WO 2012144754A3
Authority
WO
WIPO (PCT)
Prior art keywords
inhibitory effects
isolated therefrom
compound isolated
active ingredient
composition containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/KR2012/002450
Other languages
English (en)
Korean (ko)
Other versions
WO2012144754A2 (fr
Inventor
박현
김경민
송현옥
김성연
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Industry Academic Cooperation Foundation of Wonkwang University
Original Assignee
Industry Academic Cooperation Foundation of Wonkwang University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Industry Academic Cooperation Foundation of Wonkwang University filed Critical Industry Academic Cooperation Foundation of Wonkwang University
Publication of WO2012144754A2 publication Critical patent/WO2012144754A2/fr
Publication of WO2012144754A3 publication Critical patent/WO2012144754A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/22—Anacardiaceae (Sumac family), e.g. smoketree, sumac or poison oak
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fodder In General (AREA)

Abstract

L'invention concerne un extrait de Galla Rhois présentant des effets inhibiteurs, ou un composé isolé à partir de celui-ci, qui présente des effets antiviraux supérieurs contre des maladies provoquées par de nouveaux virus de la grippe, le virus de la grippe aviaire et le coronavirus qui est infectieux pour l'organisme humain ou habituellement infectieux pour les humains et les animaux, et qui peut donc être utilisé pour des compositions pharmaceutiques, des aliments fonctionnels bons pour la santé, des additifs d'aliments pour animaux ou des aliments pour animaux.
PCT/KR2012/002450 2011-04-19 2012-04-02 Composition contenant un extrait de galla rhois présentant des effets inhibiteur de virus, ou un composé isolé à partir de celui-ci, comme ingrédient actif et ses utilisations Ceased WO2012144754A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020110036241A KR101317318B1 (ko) 2011-04-19 2011-04-19 신종인플루엔자, 조류인플루엔자, 일반 및 독감감기, ｓａｒｓ 바이러스 억제 효능을 갖는 오배자 추출물 또는 이로부터 분리된 화합물을 유효성분으로 함유하는 약학 조성물
KR10-2011-0036241 2011-04-19

Publications (2)

Publication Number Publication Date
WO2012144754A2 WO2012144754A2 (fr) 2012-10-26
WO2012144754A3 true WO2012144754A3 (fr) 2013-01-10

Family

ID=47042016

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2012/002450 Ceased WO2012144754A2 (fr) 2011-04-19 2012-04-02 Composition contenant un extrait de galla rhois présentant des effets inhibiteur de virus, ou un composé isolé à partir de celui-ci, comme ingrédient actif et ses utilisations

Country Status (2)

Country Link
KR (1) KR101317318B1 (fr)
WO (1) WO2012144754A2 (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11154531B2 (en) * 2020-02-08 2021-10-26 Syneurx International (Taiwan) Corp. Compounds and pharmaceutical uses thereof
US20210236580A1 (en) * 2020-04-07 2021-08-05 Sytheon Ltd Methods and Compositions for Mitigating Symptoms of Acute Respiratory Distress Syndrome
AU2021260663A1 (en) * 2020-04-23 2022-11-10 Syneurx International (Taiwan) Corp. Compounds and pharmaceutical uses thereof
KR102456749B1 (ko) 2020-04-28 2022-10-21 서울대학교산학협력단 울금 (Curcuma longa) 추출물 또는 이로부터 분리한 세스퀴테르페노이드계 화합물을 유효성분으로 포함하는 돼지 인플루엔자 바이러스 감염의 예방 또는 치료용 조성물
CN111658631A (zh) * 2020-06-11 2020-09-15 广东盛普生命科技有限公司 没食子酸及其衍生物和结构类似物在制备抗冠状病毒药物方面的应用
CN111574571A (zh) * 2020-06-11 2020-08-25 石河子大学 一种五倍子有效部位的分离方法及其用途
US20240041854A1 (en) * 2020-07-30 2024-02-08 Otsuka Pharmaceutical Factory, Inc. Cold medicine and antiviral medicine
CN112521432B (zh) * 2020-11-25 2022-05-06 深圳市三启药物开发有限公司 一类星状棘蛋白靶向的抗呼吸道感染病毒的双功能化合物及其盐类的制备方法和应用
KR102665503B1 (ko) * 2021-04-15 2024-05-17 에이피알지 주식회사 오배자 추출물을 유효성분으로 포함하는 코로나 바이러스(SARS-CoV-2) 감염의 예방 또는 치료용 조성물
WO2023038480A1 (fr) * 2021-09-08 2023-03-16 에이피알지 주식회사 Composition pour la prévention, le traitement ou le soulagement d'une infection par le virus de la grippe, comprenant un mélange d'extrait d'agrimonia pilosa et d'extrait de galla rhois en tant que principes actifs
KR102420201B1 (ko) 2022-01-17 2022-07-13 주식회사 유이케미칼 인지질 외피 보유 바이러스 사멸기능을 가지는 친환경 방역 조성물
KR102679048B1 (ko) * 2022-04-18 2024-07-01 (주)유제이 유해 조류 기피제 조성물
KR20240045546A (ko) 2022-09-30 2024-04-08 (주)예스킨 항 인플루엔자 바이러스제

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01172330A (ja) * 1987-12-26 1989-07-07 Nisshin Flour Milling Co Ltd 家畜および家禽のサルモネラ・テイフィムリウム感染症の予防及び治療剤
JPH0625003A (ja) * 1992-04-27 1994-02-01 Showa Shell Sekiyu Kk 生薬を含有する抗ウイルス剤
KR20080084477A (ko) * 2007-03-16 2008-09-19 원광대학교산학협력단 항균 및 항바이러스 활성을 갖는 오배자 및 목단피추출물을 함유하는 조성물
KR20090072527A (ko) * 2007-12-28 2009-07-02 삼광생명과학 주식회사 항균 활성을 갖는 오배자 추출물 또는 이로부터 분리된화합물을 유효성분으로 함유하는 조성물
KR20090072526A (ko) * 2007-12-28 2009-07-02 삼광생명과학 주식회사 항균 및 항바이러스 활성을 갖는 오배자 추출물 또는이로부터 분리된 화합물을 유효성분으로 함유하는 수의학적조성물

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01172330A (ja) * 1987-12-26 1989-07-07 Nisshin Flour Milling Co Ltd 家畜および家禽のサルモネラ・テイフィムリウム感染症の予防及び治療剤
JPH0625003A (ja) * 1992-04-27 1994-02-01 Showa Shell Sekiyu Kk 生薬を含有する抗ウイルス剤
KR20080084477A (ko) * 2007-03-16 2008-09-19 원광대학교산학협력단 항균 및 항바이러스 활성을 갖는 오배자 및 목단피추출물을 함유하는 조성물
KR20090072527A (ko) * 2007-12-28 2009-07-02 삼광생명과학 주식회사 항균 활성을 갖는 오배자 추출물 또는 이로부터 분리된화합물을 유효성분으로 함유하는 조성물
KR20090072526A (ko) * 2007-12-28 2009-07-02 삼광생명과학 주식회사 항균 및 항바이러스 활성을 갖는 오배자 추출물 또는이로부터 분리된 화합물을 유효성분으로 함유하는 수의학적조성물

Also Published As

Publication number Publication date
KR101317318B1 (ko) 2013-10-14
WO2012144754A2 (fr) 2012-10-26
KR20120118707A (ko) 2012-10-29

Similar Documents

Publication Publication Date Title
WO2012144754A3 (fr) Composition contenant un extrait de galla rhois présentant des effets inhibiteur de virus, ou un composé isolé à partir de celui-ci, comme ingrédient actif et ses utilisations
WO2013091775A3 (fr) Utilisation de dérivés du cyclohéxanol comme principes actifs antimicrobiens
BR112015003376A8 (pt) composto ou sal farmaceuticamente aceitável do mesmo, composição farmacêutica e usos de quantidade eficiente de composto ou sal farmaceuticamente aceitável do mesmo ou composição farmacêutica
EA201390885A1 (ru) Азаиндолы в качестве противовирусных агентов против респираторного синцитиального вируса
WO2010111640A3 (fr) Compositions antigrippales et méthodes associées
PH12019550113A1 (en) Nucleotide hemi-sulfate salt for the treatment of hepatitis c virus
WO2012065963A3 (fr) Nouveaux composés antiviraux
WO2013179307A3 (fr) Compositions pharmaceutiques stabilisées de saxagliptine
WO2012168430A3 (fr) Polypeptides
WO2012037562A3 (fr) Compositions pharmaceutiques et nutraceutiques d'acide abscisique
WO2011049348A3 (fr) Agents antiviraux obtenus de curcuma longa, ayant des activités inhibitrices contre les grippes aviaire, espagnole et nouvelle
PH12019501359A1 (en) Polymorphs
WO2012087037A3 (fr) Nouveau bactériophage et composition antibactérienne le comprenant
EP4327880A3 (fr) Forme à l'état solide de succinate de ribociclib
WO2014121764A3 (fr) Dérivés de 6-biarylméthylamino-9-cyclopentyl-9h-purine 2-substituée, leur utilisation comme médicaments et compositions pharmaceutiques les contenant
WO2012093234A3 (fr) Arabinogalactanes sulfates, apiogalacturonanes et heteroglycanes sulfates pour le traitement des maladies causees par les virus influenza
WO2013109388A3 (fr) Dérivés de 1,5-naphtyridine et inhibiteurs de melk les contenant
WO2011122872A3 (fr) Composition comprenant du coumestrol ou un extrait de fèves contenant du coumestrol
WO2008146172A3 (fr) Composés présentant une activité antiparasitaire, leurs applications au traitement de maladies infectieuses provoquées par des apicomplexans
WO2013128379A3 (fr) Formes polymorphes cristallines de linagliptine
WO2009003719A3 (fr) Dérivés d'indane-amine, leur préparation et leur utilisation comme médicaments
MX2016001422A (es) Composicion farmaceutica de fingolimod.
WO2011149301A3 (fr) Composition comprenant l'extrait de physalis alkekengi var. francheti hort en tant que principe actif pour la prévention et le traitement de maladies inflammatoires
WO2016006974A3 (fr) Nouveaux dérivés triazolopyrimidinone ou triazolopyridinone et leur utilisation
WO2016006975A3 (fr) Nouveaux dérivés imidazotriazinone ou imidazopyrazinone et leur utilisation

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12773514

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 12773514

Country of ref document: EP

Kind code of ref document: A2